New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.
Michigan Medicine is renowned for groundbreaking clinical, basic science and medical educational research, with nearly 7,000 papers published annually by faculty and trainees. Here, Lab Notes highlights a selection of those articles in addition to ones covered as stories on the Michigan Health Lab blog.
Research suggests the possibility of a more general phenomenon, applicable to the growth of other primary cell types.
In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.